Effect of aprotinin on activated clotting time whole blood and plasma heparin measurements

This publication has 26 references indexed in Scilit:

• Comparison of High-Dose Thrombin Time with Activated Clotting Time for Monitoring of Anticoagulant Effects of Heparin in Cardiac Surgical Patients
  Anesthesia & Analgesia, 1994
• Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest
  The Annals of Thoracic Surgery, 1993
• Activated Clotting Time, Anticoagulation, Use of Heparin, and Thrombin Activation during Extra-corporeal Circulation: Changes under Aprotinin Therapy
  The Thoracic and Cardiovascular Surgeon, 1993
• The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement
  Blood Coagulation & Fibrinolysis, 1993
• Monitoring of Heparin-induced Anticoagulation with Kaolinactivated Clotting Time in Cardiac Surgical Patients Treated with Aprotinin
  Anesthesiology, 1992
• Comparison study of the Hepcon System Four and the Hemostasis Management System
  Perfusion, 1991
• Heparin Resistance prior to Cardiopulmonary Bypass
  Anesthesiology, 1986
• Fresh Frozen Plasma: A Solution to Heparin Resistance during Cardiopulmonary Bypass
  The Annals of Thoracic Surgery, 1984
• Lack of Correlation Between Activated Clotting Time and Plasma Heparin During Cardiopulmonary Bypass
  Annals of Surgery, 1981
• THE INFLUENCE OF TISSUE SOURCE, SALT AND MOLECULAR WEIGHT ON HEPARIN ACTIVITY
  Scandinavian Journal of Haematology, 1980